PGK1 and amyotrophic lateral sclerosis: Previous experimental evidence suggests that targeting the glycolytic enzyme PGK1 may confer neuroprotection across various neurodegeneration paradigms.29, 30, 31 We therefore wanted to establish whether this neuroprotection could be translated to motor neurons in the context of ALS.